
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.96%
-1.46%
+2.36%
-0.05%
-0.85%
Most Trending
-2.96%
-1.46%
+2.36%
-0.05%
-0.85%
13 Jan 2026$MRNA led the charge with a 15% jump, fueled by optimism in its pipeline and renewed investor confidence in biotech growth, even as global markets opened in red.
$INTC surged 8.62% after KeyBanc raised its rating to Overweight, citing strong demand from cloud providers. AMD $AMD also rose in early trading, echoing Intel momentum as investors weigh the growing position in the processor and accelerated computing market.
$META slipped 2.18% amid reports that Meta Platforms and EssilorLuxottica are discussing doubling production of smart glasses to 20 million units annually. While Meta remains focused on artificial intelligence, intensifying competition from Google $GOOGL in wearable computing seems to weigh on the stock.
$GOOGL continued its steady ascent, up 1.4%, recently surpassing a $4 trillion market cap. The long-term partnership with Apple to integrate AI models into Siri could reinforce its dominance, even as investors closely monitor execution timelines.
$JPM posted a mixed picture. Fourth-quarter net profit fell about 7%, yet revenues climbed to $182.4 billion from $177.6 billion last year, reflecting growth in fees and interest income.
$BK showed modest weakness despite beating earnings estimates with a 7% revenue rise, suggesting the market is weighing broader sector conditions rather than short-term beats.
$DAL struggled, down 2.46% despite stronger-than-expected fourth-quarter earnings. Investors reacted to the 2026 guidance of $6.50–$7.50 per share, below expectations, signaling caution over future growth in the airline industry.
$LHX climbed 0.65% after announcing plans to spin off its missile business into a separate public company. The U.S. Department of Defense plans to invest $1 billion via preferred equity convertible into common stock, a move that could unlock significant value and reset investor sentiment.
$ABBV dipped 0.13% after announcing a three-year agreement with the U.S. government to lower drug prices and invest in domestic R&D, leaving the market assessing potential medium-term margin impacts.
$RVTY gained 5.38% after raising its annual forecast, reinforcing confidence in its ability to sustain growth in the life sciences sector.
09:20 AM
Yesterday at 08:36
Yesterday at 08:29
Yesterday at 01:43
Yesterday at 01:40
Yesterday at 01:35
Yesterday at 01:02
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
09:20 AM
Yesterday at 08:36
Yesterday at 08:29
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.